Actively Recruiting
Aveir DR Real-World Evidence Post-Approval Study
Led by Abbott Medical Devices · Updated on 2025-04-04
1805
Participants Needed
1
Research Sites
322 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this post-approval study is to evaluate the long-term safety of the dual-chamber Aveir DR leadless pacemaker using real-world evidence methods.
CONDITIONS
Official Title
Aveir DR Real-World Evidence Post-Approval Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Implanted with an Aveir DR leadless pacemaker
- Continuous enrollment in Medicare Part A and Part B for 12 months prior to implant
- Continuous enrollment in Medicare Part A and Part B for at least 30 days after implant, except in case of death within the 30-day period
- Ability to link medical data with Medicare fee-for-service data
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Abbott
Sylmar, California, United States, 91342
Actively Recruiting
Research Team
N
Nicole Harbert
CONTACT
S
Stephanie Delgado
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here